541 related articles for article (PubMed ID: 17511970)
21. Inhibition of Fatty Acid Amide Hydrolase Improves Depressive-Like Behaviors Independent of Its Peripheral Antinociceptive Effects in a Rat Model of Neuropathic Pain.
Jiang HX; Ke BW; Liu J; Ma G; Hai KR; Gong DY; Yang Z; Zhou C
Anesth Analg; 2019 Aug; 129(2):587-597. PubMed ID: 29863609
[TBL] [Abstract][Full Text] [Related]
22. Inhibitors of fatty acid amide hydrolase reduce carrageenan-induced hind paw inflammation in pentobarbital-treated mice: comparison with indomethacin and possible involvement of cannabinoid receptors.
Holt S; Comelli F; Costa B; Fowler CJ
Br J Pharmacol; 2005 Oct; 146(3):467-76. PubMed ID: 16100529
[TBL] [Abstract][Full Text] [Related]
23. Blockade of alcohol escalation and "relapse" drinking by pharmacological FAAH inhibition in male and female C57BL/6J mice.
Zhou Y; Schwartz BI; Giza J; Gross SS; Lee FS; Kreek MJ
Psychopharmacology (Berl); 2017 Oct; 234(19):2955-2970. PubMed ID: 28730283
[TBL] [Abstract][Full Text] [Related]
24. The FAAH inhibitor URB597 efficiently reduces tyrosine hydroxylase expression through CB₁- and FAAH-independent mechanisms.
Bosier B; Muccioli GG; Lambert DM
Br J Pharmacol; 2013 Jun; 169(4):794-807. PubMed ID: 22970888
[TBL] [Abstract][Full Text] [Related]
25. Antidepressant-like behavioral and neurochemical effects of the citrus-associated chemical apigenin.
Yi LT; Li JM; Li YC; Pan Y; Xu Q; Kong LD
Life Sci; 2008 Mar; 82(13-14):741-51. PubMed ID: 18308340
[TBL] [Abstract][Full Text] [Related]
26. Long-term administration of fatty acid amide hydrolase inhibitor (URB597) to rats with spontaneous hypertension disturbs liver redox balance and phospholipid metabolism.
Biernacki M; Ambrożewicz E; Gęgotek A; Toczek M; Skrzydlewska E
Adv Med Sci; 2019 Mar; 64(1):15-23. PubMed ID: 30243113
[TBL] [Abstract][Full Text] [Related]
27. Effects of a short-term exposure to alcohol in rats on FAAH enzyme and CB1 receptor in different brain areas.
Rubio M; de Miguel R; Fernández-Ruiz J; Gutiérrez-López D; Carai MA; Ramos JA
Drug Alcohol Depend; 2009 Jan; 99(1-3):354-8. PubMed ID: 18922654
[TBL] [Abstract][Full Text] [Related]
28. Effects of Rhodiola rosea L. extract on behavioural and physiological alterations induced by chronic mild stress in female rats.
Mattioli L; Funari C; Perfumi M
J Psychopharmacol; 2009 Mar; 23(2):130-42. PubMed ID: 18515456
[TBL] [Abstract][Full Text] [Related]
29. Antidepressant-like effect of trans-resveratrol in chronic stress model: behavioral and neurochemical evidences.
Yu Y; Wang R; Chen C; Du X; Ruan L; Sun J; Li J; Zhang L; O'Donnell JM; Pan J; Xu Y
J Psychiatr Res; 2013 Mar; 47(3):315-22. PubMed ID: 23174668
[TBL] [Abstract][Full Text] [Related]
30. Effect of Fatty Acid Amide Hydrolase Inhibitor URB597 on Orofacial Pain Perception in Rats.
Zubrzycki M; Zubrzycka M; Wysiadecki G; Szemraj J; Jerczynska H; Stasiolek M
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563056
[TBL] [Abstract][Full Text] [Related]
31. Preservation of striatal cannabinoid CB1 receptor function correlates with the antianxiety effects of fatty acid amide hydrolase inhibition.
Rossi S; De Chiara V; Musella A; Sacchetti L; Cantarella C; Castelli M; Cavasinni F; Motta C; Studer V; Bernardi G; Cravatt BF; Maccarrone M; Usiello A; Centonze D
Mol Pharmacol; 2010 Aug; 78(2):260-8. PubMed ID: 20424126
[TBL] [Abstract][Full Text] [Related]
32. Enhancement of endocannabinoid signalling during adolescence: Modulation of impulsivity and long-term consequences on metabolic brain parameters in early maternally deprived rats.
Marco EM; Adriani W; Canese R; Podo F; Viveros MP; Laviola G
Pharmacol Biochem Behav; 2007 Feb; 86(2):334-45. PubMed ID: 17101171
[TBL] [Abstract][Full Text] [Related]
33. Crosstalk between liver antioxidant and the endocannabinoid systems after chronic administration of the FAAH inhibitor, URB597, to hypertensive rats.
Biernacki M; Łuczaj W; Gęgotek A; Toczek M; Bielawska K; Skrzydlewska E
Toxicol Appl Pharmacol; 2016 Jun; 301():31-41. PubMed ID: 27086176
[TBL] [Abstract][Full Text] [Related]
34. Local enhancement of cannabinoid CB1 receptor signalling in the dorsal hippocampus elicits an antidepressant-like effect.
McLaughlin RJ; Hill MN; Morrish AC; Gorzalka BB
Behav Pharmacol; 2007 Sep; 18(5-6):431-8. PubMed ID: 17762511
[TBL] [Abstract][Full Text] [Related]
35. Antidepressant-like effects of curcumin on serotonergic receptor-coupled AC-cAMP pathway in chronic unpredictable mild stress of rats.
Li YC; Wang FM; Pan Y; Qiang LQ; Cheng G; Zhang WY; Kong LD
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Apr; 33(3):435-49. PubMed ID: 19302828
[TBL] [Abstract][Full Text] [Related]
36. Effects of the fatty acid amide hydrolase inhibitor URB597 on the sleep-wake cycle, c-Fos expression and dopamine levels of the rat.
Murillo-Rodríguez E; Vázquez E; Millán-Aldaco D; Palomero-Rivero M; Drucker-Colin R
Eur J Pharmacol; 2007 May; 562(1-2):82-91. PubMed ID: 17336288
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of fatty acid amide hydrolase inhibition in murine models of emotionality.
Naidu PS; Varvel SA; Ahn K; Cravatt BF; Martin BR; Lichtman AH
Psychopharmacology (Berl); 2007 May; 192(1):61-70. PubMed ID: 17279376
[TBL] [Abstract][Full Text] [Related]
38. Estradiol valerate elicits antidepressant-like effects in middle-aged female rats under chronic mild stress.
Romano-Torres M; Fernández-Guasti A
Behav Pharmacol; 2010 Mar; 21(2):104-11. PubMed ID: 20168212
[TBL] [Abstract][Full Text] [Related]
39. Reducing endocannabinoid metabolism with the fatty acid amide hydrolase inhibitor, URB597, fails to modify reinstatement of morphine-induced conditioned floor preference and naloxone-precipitated morphine withdrawal-induced conditioned floor avoidance.
McCallum AL; Limebeer CL; Parker LA
Pharmacol Biochem Behav; 2010 Oct; 96(4):496-500. PubMed ID: 20643159
[TBL] [Abstract][Full Text] [Related]
40. Redox system and phospholipid metabolism in the kidney of hypertensive rats after FAAH inhibitor URB597 administration.
Biernacki M; Ambrożewicz E; Gęgotek A; Toczek M; Bielawska K; Skrzydlewska E
Redox Biol; 2018 May; 15():41-50. PubMed ID: 29197803
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
